These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10073329

  • 1. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
    Gupta SK, Sathyan G.
    J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
    [Abstract] [Full Text] [Related]

  • 2. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM.
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [Abstract] [Full Text] [Related]

  • 3. Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride.
    Sathyan G, Chancellor MB, Gupta SK.
    Br J Clin Pharmacol; 2001 Oct; 52(4):409-17. PubMed ID: 11678784
    [Abstract] [Full Text] [Related]

  • 4. Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages: severity-dependent treatment of the overactive bladder.
    Preik M, Albrecht D, O'Connell M, Hampel C, Anderson R.
    BJU Int; 2004 Oct; 94(6):821-7. PubMed ID: 15476516
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutynin.
    Reiz JL, Salem P, Darke AC.
    J Clin Pharmacol; 2007 Mar; 47(3):351-7. PubMed ID: 17322147
    [Abstract] [Full Text] [Related]

  • 6. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK, Sathyan G, Lindemulder EA, Ho PL, Sheiner LB, Aarons L.
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical study.
    Krause P, Fuhr U, Schnitker J, Albrecht U, Stein R, Rubenwolf P.
    J Urol; 2013 Nov; 190(5):1791-7. PubMed ID: 23669567
    [Abstract] [Full Text] [Related]

  • 12. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.
    Davila GW, Daugherty CA, Sanders SW, Transdermal Oxybutynin Study Group.
    J Urol; 2001 Jul; 166(1):140-5. PubMed ID: 11435842
    [Abstract] [Full Text] [Related]

  • 13. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF, Ducharme MP, DiMarco M, Di Spirito M, Morelli G, Tippabhotla SK, Badri N, Rampal A, Monif T.
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q, Janssens L, Verhaeghe T, Brashear HR, Truyen L.
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [Abstract] [Full Text] [Related]

  • 16. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M.
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.